piracetam has been researched along with Dementia, Vascular in 8 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Dementia, Vascular: An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This article investigated the clinical effects of piracetam with nimodipine in the treatment of vascular dementia (VD) after cerebral infarction." | 7.96 | Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction. ( Lei, Z; Wenjing, L; Zhaomin, C; Zongfang, Z, 2020) |
| "Patients with cognitive decline from Alzheimer's disease and/or cerebrovascular origin have received the drug, in the first 4 weeks in 4800, later 2400 mg daily doses." | 6.69 | [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia]. ( Paksy, A; Tariska, P, 2000) |
| "This article investigated the clinical effects of piracetam with nimodipine in the treatment of vascular dementia (VD) after cerebral infarction." | 3.96 | Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction. ( Lei, Z; Wenjing, L; Zhaomin, C; Zongfang, Z, 2020) |
| "Patients with cognitive decline from Alzheimer's disease and/or cerebrovascular origin have received the drug, in the first 4 weeks in 4800, later 2400 mg daily doses." | 2.69 | [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia]. ( Paksy, A; Tariska, P, 2000) |
| "Vascular dementia is considered a vascular cognitive impairment disease caused by neuronal degeneration in the brain." | 1.51 | Neuroprotective effects of zafirlukast, piracetam and their combination on L-Methionine-induced vascular dementia in rats. ( Bahnasawy, NH; Elnoby, AS; Fayez, AM; Hassan, O, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xia, M | 1 |
| Ruan, Z | 1 |
| Chen, B | 1 |
| Wang, Y | 1 |
| Zhou, Z | 1 |
| Ren, S | 1 |
| Wu, L | 1 |
| Tang, N | 1 |
| Zongfang, Z | 1 |
| Wenjing, L | 1 |
| Zhaomin, C | 1 |
| Lei, Z | 1 |
| Furtado, I | 1 |
| Gonçalves, F | 1 |
| Gonçalves, J | 1 |
| Neves, J | 1 |
| Fayez, AM | 1 |
| Elnoby, AS | 1 |
| Bahnasawy, NH | 1 |
| Hassan, O | 1 |
| Zakharov, VV | 1 |
| Gustov, AA | 1 |
| Smirnov, AA | 1 |
| Korshunova, IuA | 1 |
| Andrianova, EV | 1 |
| Stoppe, G | 1 |
| Sandholzer, H | 1 |
| Staedt, J | 1 |
| Winter, S | 1 |
| Kiefer, J | 1 |
| Rüther, E | 1 |
| Tariska, P | 1 |
| Paksy, A | 1 |
1 trial available for piracetam and Dementia, Vascular
| Article | Year |
|---|---|
[Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition; Cognition Disorders; Dementia; Dementia, Vasc | 2000 |
7 other studies available for piracetam and Dementia, Vascular
| Article | Year |
|---|---|
Wuzang Wenyang Huayu decoction regulates differentially expressed transcripts in the rats' hippocampus after cerebral hypoperfusion.
Topics: Animals; Behavior, Animal; Dementia, Vascular; Drugs, Chinese Herbal; Gene Expression Profiling; Gen | 2020 |
Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction.
Topics: Aged; Calcium Channel Blockers; Case-Control Studies; Cerebral Infarction; Cerebrovascular Circulati | 2020 |
Continuous subcutaneous levetiracetam in end-of-life care.
Topics: Aged, 80 and over; Anticonvulsants; Dementia, Vascular; Disease Progression; Female; Humans; Infusio | 2018 |
Neuroprotective effects of zafirlukast, piracetam and their combination on L-Methionine-induced vascular dementia in rats.
Topics: Acetylcholine; Animals; Brain; Brain Chemistry; Dementia, Vascular; Drug Therapy, Combination; Indol | 2019 |
[Vinpotropil in the treatment of dyscirculatory encephalopathy with cognitive impairment without dementia].
Topics: Adult; Aged; Cognition Disorders; Dementia, Vascular; Dizziness; Drug Administration Schedule; Drug | 2010 |
[Phenotropil in the treatment of vascular encephalopathy].
Topics: Dementia, Vascular; Female; Humans; Male; Middle Aged; Nootropic Agents; Piracetam; Psychiatric Stat | 2006 |
Prescribing practice with cognition enhancers in outpatient care: are there differences regarding type of dementia?--Results of a representative survey in lower Saxony, Germany.
Topics: Adult; Alzheimer Disease; Ambulatory Care; Data Collection; Dementia; Dementia, Vascular; Female; Ge | 1996 |